64
Views
2
CrossRef citations to date
0
Altmetric
Review

Prevention of acute coronary events in noncardiac surgery: β-blocker therapy and coronary revascularization

, , , , &
Pages 521-532 | Published online: 10 Jan 2014

References

  • Mangano DT. Perioperative cardiac morbidity. Anesthesiology72(1), 153–184 (1990).
  • Mangano DT. Adverse outcomes after surgery in the year 2001 – a continuing odyssey. Anesthesiology88(3), 561–564 (1998).
  • Mangano DT, Goldman L. Preoperative assessment of patients with known or suspected coronary disease. N. Engl. J. Med.333(26), 1750–1756 (1995).
  • McCann RL, Clements FM. Silent myocardial ischemia in patients undergoing peripheral vascular surgery: incidence and association with perioperative cardiac morbidity and mortality. J. Vasc. Surg.9(4), 583–587 (1989).
  • Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM; The Study of Perioperative Ischemia Research Group. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N. Engl. J. Med.323(26), 1781–1788 (1990).
  • Badner NH, Knill RL, Brown JE, Novick TV, Gelb AW. Myocardial infarction after noncardiac surgery. Anesthesiology88(3), 572–578 (1998).
  • Haagensen R, Steen PA. Perioperative myocardial infarction. Br. J. Anaesth.61(1), 24–37 (1988).
  • Ouyang P, Gerstenblith G, Furman WR, Golueke PJ, Gottlieb SO. Frequency and significance of early postoperative silent myocardial ischemia in patients having peripheral vascular surgery. Am. J. Cardiol.64(18), 1113–1116 (1989).
  • Hertzer NR, Beven EG, Young JR et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann. Surg.199(2), 223–233 (1984).
  • Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation116(17), 1971–1996 (2007).
  • Mancia G, De Backer G, Dominiczak A et al. [ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev. Esp. Cardiol.60(9), 968.e961–968.e994 (2007).
  • Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J.29(19), 2388–2442 (2008).
  • Bassand JP, Hamm CW, Ardissino D et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur. Heart J.28(13), 1598–1660 (2007).
  • Yeager MP, Fillinger MP, Hettleman BD, Hartman GS. Perioperative β-blockade and late cardiac outcomes: a complementary hypothesis. J. Cardiothorac. Vasc. Anesth.19(2), 237–241 (2005).
  • Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc. Res.33(2), 243–257 (1997).
  • Cruickshank JM. β-blockers continue to surprise us. Eur. Heart J.21(5), 354–364 (2000).
  • Sun JZ, Maguire D. How to prevent perioperative myocardial injury: the conundrum continues. Am. Heart J.154(6), 1021–1028 (2007).
  • Priebe HJ. Perioperative myocardial infarction – aetiology and prevention. Br. J. Anaesth.95(1), 3–19 (2005).
  • Wallace A, Layug B, Tateo I et al.; McSPI Research Group. Prophylactic atenolol reduces postoperative myocardial ischemia. Anesthesiology88(1), 7–17 (1998).
  • Redelmeier D, Scales D, Kopp A. β blockers for elective surgery in elderly patients: population based, retrospective cohort study. BMJ331(7522), 932 (2005).
  • Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative β-blocker therapy and mortality after major noncardiac surgery. N. Engl. J. Med.353(4), 349–361 (2005).
  • Feringa HH, Bax JJ, Boersma E et al. High-dose β-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients. Circulation114(1 Suppl.), I344–I349 (2006).
  • Mangano DT, Layug EL, Wallace A, Tateo I; Multicenter Study of Perioperative Ischemia Research Group. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N. Engl. J. Med.335(23), 1713–1720 (1996).
  • Raby KE, Brull SJ, Timimi F et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth. Analg.88(3), 477–482 (1999).
  • Poldermans D, Boersma E, Bax JJ et al.; Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N. Engl. J. Med.341(24), 1789–1794 (1999).
  • Devereaux PJ, Yang H, Yusuf S et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet371(9627), 1839–1847 (2008).
  • Brady AR, Gibbs JS, Greenhalgh RM, Powell JT, Sydes MR. Perioperative β-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J. Vasc. Surg.41(4), 602–609 (2005).
  • Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative β-blockade: results of the Metoprolol After Vascular Surgery (MAVS) study, a randomized controlled trial. Am. Heart J.152(5), 983–990 (2006).
  • Juul AB, Wetterslev J, Gluud C et al. Effect of perioperative β-blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ332(7556), 1482 (2006).
  • Zaugg M, Bestmann L, Wacker J et al. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss β Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up. Anesthesiology107(1), 33–44 (2007).
  • Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli FH. Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis. Lancet372(9654), 1962–1976 (2008).
  • Boersma E, Poldermans D. β blockers in non-cardiac surgery: haemodynamic data needed. Lancet372(9654), 1930–1932 (2008).
  • Boersma E, Poldermans D, Bax JJ et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and β-blocker therapy. JAMA285(14), 1865–1873 (2001).
  • Fleisher LA, Poldermans D. Perioperative β-blockade: where do we go from here? Lancet371(9627), 1813–1814 (2008).
  • The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet353(9146), 9–13 (1999).
  • Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G. Does tight heart rate control improve β-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Anesth. Analg.106(4), 1039–1048 (2008).
  • Maling TJ, Dollery CT. Changes in blood pressure, heart rate, and plasma noradrenaline concentration after sudden withdrawal of propranolol. Br. Med. J.2(6186), 366–367 (1979).
  • Shammash JB, Trost JC, Gold JM, Berlin JA, Golden MA, Kimmel SE. Perioperative β-blocker withdrawal and mortality in vascular surgical patients. Am. Heart J.141(1), 148–153 (2001).
  • Hoeks SE, Scholte Op Reimer WJ, van Urk H et al. Increase of 1-year mortality after perioperative β-blocker withdrawal in endovascular and vascular surgery patients. Eur. J. Vasc. Endovasc. Surg.33(1), 13–19 (2007).
  • Sipahi I, Tuzcu EM, Wolski KE et al. β-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials. Ann. Intern. Med.147(1), 10–18 (2007).
  • Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative β-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society for Vascular Medicine and Biology. J. Am. Coll. Cardiol.47(11), 2343–2355 (2006).
  • Siddiqui AK, Ahmed S, Delbeau H, Conner D, Mattana J. Lack of physician concordance with guidelines on the perioperative use of β-blockers. Arch. Intern. Med.164(6), 664–667 (2004).
  • Hertzer NR, Young JR, Beven EG et al. Late results of coronary bypass in patients presenting with lower extremity ischemia: the Cleveland Clinic Study. Ann. Vasc. Surg.1(4), 411–419 (1987).
  • Hertzer NR, Young JR, Beven EG et al. Late results of coronary bypass in patients with infrarenal aortic aneurysms. The Cleveland Clinic Study. Ann. Surg.205(4), 360–367 (1987).
  • Gottlieb A, Banoub M, Sprung J, Levy PJ, Beven M, Mascha EJ. Perioperative cardiovascular morbidity in patients with coronary artery disease undergoing vascular surgery after percutaneous transluminal coronary angioplasty. J. Cardiothorac. Vasc. Anesth.12(5), 501–506 (1998).
  • Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the medicare population. Anesth. Analg.89(4), 849–855 (1999).
  • Back MR, Stordahl N, Cuthbertson D, Johnson BL, Bandyk DF. Limitations in the cardiac risk reduction provided by coronary revascularization prior to elective vascular surgery. J. Vasc. Surg.36(3), 526–533 (2002).
  • Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ; CASS Investigators and University of Michigan Heart Care Program. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. Coronary Artery Surgery Study. Circulation96(6), 1882–1887 (1997).
  • McFalls EO, Ward HB, Moritz TE et al. Coronary-artery revascularization before elective major vascular surgery. N. Engl. J. Med.351(27), 2795–2804 (2004).
  • Garcia S, Moritz TE, Ward HB et al. Usefulness of revascularization of patients with multivessel coronary artery disease before elective vascular surgery for abdominal aortic and peripheral occlusive disease. Am. J. Cardiol.102(7), 809–813 (2008).
  • Raghunathan A, Rapp JH, Littooy F et al. Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: a subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial. J. Vasc. Surg.43(6), 1175–1182 (2006).
  • Ward HB, Kelly RF, Thottapurathu L et al. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery. Ann. Thorac. Surg.82(3), 795–800; discussion 800–791 (2006).
  • Poldermans D, Schouten O, Vidakovic R et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J. Am. Coll. Cardiol.49(17), 1763–1769 (2007).
  • Landesberg G, Mosseri M, Wolf YG et al. Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery. Circulation108(2), 177–183 (2003).
  • Landesberg G, Berlatzky Y, Bocher M et al. A clinical survival score predicts the likelihood to benefit from preoperative thallium scanning and coronary revascularization before major vascular surgery. Eur. Heart J.28(5), 533–539 (2007).
  • Landesberg G, Mosseri M. PRO: Preoperative coronary revascularization in high-risk patients undergoing vascular surgery. Anesth. Analg.106(3), 759–763 (2008).
  • Damen J, Hagemeijer JW, van den Broek L, Poldermans D. [Prevention of perioperative cardiac complications in non-cardiac surgery: an evidence-based guideline]. Ned. Tijdschr. Geneeskd.152(48), 2612–2616 (2008).
  • Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. J. Am. Coll. Cardiol.49(22), 2145–2150 (2007).
  • Garcia S, McFalls EO. CON: preoperative coronary revascularization in high-risk patients undergoing vascular surgery. Anesth. Analg.106(3), 764–766 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.